Inmune Bio (INMB) Deferred Taxes (2022 - 2025)
Inmune Bio (INMB) posted Deferred Taxes of -$511000.0 for Q3 2025, down 1748.39% sequentially from $31000.0 in Q2 2025, and down 1925.0% YoY from $28000.0 in Q3 2024.
Inmune Bio (INMB) Deferred Taxes (2022 - 2025) Analysis & Trends
Inmune Bio has reported Deferred Taxes for 4 years, with the latest figure at -$511000.0 in Q3 2025.
- Quarterly Deferred Taxes fell 1925.0% year-over-year to -$511000.0 in Q3 2025, while the trailing twelve-month figure through Dec 2025 was -$517000.0 (down 1946.43% YoY) and the FY2025 annual result came in at -$517000.0, down 1946.43% from the prior year.
- Deferred Taxes declined to -$511000.0 in Q3 2025 per INMB's latest filing, from $31000.0 in the prior quarter.
- Over five years, Deferred Taxes peaked at $302000.0 in Q3 2022 and troughed at -$511000.0 in Q3 2025.
- A 4-year average of -$36615.4 and a median of -$25000.0 in 2023 frame the typical range for Deferred Taxes.
- The widest YoY moves for Deferred Taxes: up 3000.0% in 2025, down 1925.0% in 2025.
- Over 4 years, Deferred Taxes stood at -$162000.0 in 2022, then soared by 95.68% to -$7000.0 in 2023, then sank by 357.14% to -$32000.0 in 2024, then slumped by 1496.88% to -$511000.0 in 2025.
- According to Business Quant data, Deferred Taxes over the past three periods registered -$511000.0, $31000.0, and -$37000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.64 Bn | 130.78 Bn | 2.84 Bn | -69.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.89 Bn | 77.90 Bn | 3.93 Bn | 194.40 Mn |
| 3 | Argenx Se | 65.11 Bn | 59.93 Bn | 1.37 Bn | - |
| 4 | Moderna | 55.83 Bn | 50.69 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.01 Bn | 36.91 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.63 Bn | 28.32 Bn | 992.69 Mn | 2.66 Mn |
| 7 | BioNTech SE | 27.65 Bn | 9.26 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.30 Bn | 26.47 Bn | - | - |
| 10 | Inmune Bio | 60.78 Mn | 42.37 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -511,000.00 |
| Jun 30, 2025 | 31,000.00 |
| Mar 31, 2025 | -37,000.00 |
| Dec 31, 2024 | -32,000.00 |
| Sep 30, 2024 | 28,000.00 |
| Jun 30, 2024 | 1,000.00 |
| Mar 31, 2024 | 31,000.00 |
| Dec 31, 2023 | -7,000.00 |
| Sep 30, 2023 | -64,000.00 |
| Jun 30, 2023 | -31,000.00 |
| Mar 31, 2023 | -25,000.00 |
| Dec 31, 2022 | -162,000.00 |
| Sep 30, 2022 | 302,000.00 |